Proprinal

Quick links to important sections

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Proprinal

Property Description
Active ingredient Ibuprofen (INN)
Form Oral preparations (tablet, capsule, suspension)
Pharmacological class Non-Steroidal Anti-Inflammatory Drug (NSAID)
Common purpose Management of pain, inflammation, and fever
Origin Synthetic, propionic acid derivative

What Type of Medicine is Proprinal?

Proprinal is a pharmaceutical preparation that utilizes the active ingredient Ibuprofen. It is officially classified as a Non-Steroidal Anti-Inflammatory Drug (NSAID), a widely recognized pharmacological category. This grouping dictates the medication's three principal actions: acting as an analgesic (for pain), an antipyretic (for fever), and an anti-inflammatory agent (for swelling).

Ibuprofen is derived from propionic acid and was the first compound of its chemical group to be introduced. Ibuprofen is a primary over-the-counter and prescription agent. This means the medicine is a standard, highly studied choice for addressing discomfort and elevated body temperature. Proprinal is available as an oral preparation, commonly manufactured in solid dosage forms, such as tablets and capsules, and in liquid suspensions, offering flexibility for systemic administration across various patient groups.

Proprinal’s Composition and General Purpose

The medication is a single-ingredient product composed exclusively of Ibuprofen, a synthetic compound which ensures its chemical consistency. The final product is formulated with various inactive excipients necessary to achieve the stable oral forms.

The general purpose of Proprinal is to provide broad symptomatic relief by addressing the root causes of discomfort. For instance, it may be used to manage the mild-to-moderate discomfort and inflammation associated with musculoskeletal strain or the headache and fever that accompany common illness. Its efficacy is linked to its primary mechanism of Inhibition of cyclooxygenase enzymes. Ibuprofen is utilized globally for its analgesic, anti-inflammatory, and antipyretic properties. In simple terms, its core benefit is reducing the chemical signals that mediate pain and heat.

Regulatory References

  1. EMA review on cardiovascular risk of high-dose ibuprofen

What side effects are possible with Proprinal?

Possible Side Effects and Safety Information for Proprinal

Serious and Clinically Significant Adverse Reactions

Regulatory agencies, including the FDA and EMA, have documented serious risks associated with this drug, which is a Nonsteroidal Anti-inflammatory Drug (NSAID). Boxed Warnings highlight two major categories of serious, potentially fatal adverse events:

  • Cardiovascular Thrombotic Events: Proprinal use increases the risk of serious, life-threatening events such as myocardial infarction (heart attack) and stroke. This risk can begin early in treatment and may increase with the duration of use and at higher doses. The drug is contraindicated for the management of peri-operative pain in the setting of Coronary Artery Bypass Graft (CABG) surgery.
  • Gastrointestinal (GI) Adverse Events: The drug increases the risk of serious GI inflammation, bleeding, ulceration, and perforation of the stomach or intestines, which can be fatal. These events may occur without warning.

Adverse Reaction Categorization

Side effects are categorized by frequency (based on ICH/CIOMS style): Very Common reactions (occurring in 10% of patients) may include headache, hypokalemia, and increased blood urea. Common reactions (1% to < 10%) include dizziness, nervousness, cough, and gastrointestinal effects like nausea, vomiting, or fluid retention. Rare but serious effects involve the Dermatologic/Hypersensitivity system, such as severe skin reactions (e.g., Stevens-Johnson Syndrome) and anaphylaxis.

Population-Specific Safety Considerations

  • Elderly Patients (Age 60 or older): This population has a higher risk for serious GI bleeding.
  • Pregnancy: Use of Proprinal at 20 weeks or later in pregnancy must be avoided as it can cause fetal heart or kidney problems and may lead to complications during delivery.
  • Pre-existing Conditions: Patients with existing cardiovascular disease, hypertension, or history of GI bleeding/ulcers are at higher risk for serious adverse events.

Safety-Related Restrictions

Proprinal is contraindicated in patients with a history of asthma, hives, or other allergic-type reactions to aspirin or other NSAIDs. Use of the smallest effective dose for the shortest possible duration is a general safety principle to minimize potential risks, which appear to be greater with higher dose and longer exposure.

Overdose and Emergency Response

Overdose and When to Seek Help

The official regulatory documentation for Proprinal (Ibuprofen) defines a clear set of clinical signs and required emergency actions in the event of over-ingestion. Documented overdose presentations commonly involve gastrointestinal effects such as nausea, vomiting, and abdominal pain. Central Nervous System (CNS) signs may include drowsiness, dizziness, and headache, alongside manifestations like tinnitus and nystagmus.

Overdose can lead to severe, life-threatening outcomes, including acute renal failure, hepatic dysfunction, metabolic acidosis, and severe CNS events such as seizures and coma. Regulators mandate that emergency medical care be sought immediately for any suspected overdose, even if the individual remains asymptomatic, due to the risk of delayed systemic toxicity. There is no specific antidote known for Ibuprofen overdose; therefore, management is limited to symptomatic and supportive treatment, often requiring hospital monitoring of vital signs and laboratory parameters, including renal and hepatic function.

Official labeling notes a specific risk of CNS toxicity (convulsions, coma) being more common and serious in the pediatric population following ingestion of large quantities. Gastrointestinal decontamination, such as the use of activated charcoal, may be considered if administered within one hour of a potentially toxic ingestion.

Therapeutic Uses of Proprinal

What Proprinal Treats: Main Uses and Benefits

Proprinal (Propranolol) is generally used to provide supportive, short-term symptomatic relief across a range of conditions where sudden or intensified symptoms may affect functional stability. The medicine is commonly used for managing symptoms associated with cardiovascular needs, essential tremor, and anxiety-related physical manifestations.


Easing Episodic Symptom Discomfort

This domain covers groups of symptoms that may appear suddenly or fluctuate over time, leading to temporary functional strain. Proprinal is applied in clinical settings that involve acute or unstable symptom patterns, such as the physical manifestations of anxiety or migraine. It may offer symptomatic support that assists patients in coping more steadily and supports the easing of the overall symptom burden. It supports the patient during difficult episodes by easing distress and helps maintain a sense of stability when symptoms are more noticeable.

Quick Fact: Relief for Symptoms that interfere with daily functioning


Support for Acute Tension and Disruptive Patterns

Proprinal is applied in contexts marked by increased discomfort or physiological tension, where short-term symptomatic assistance is needed for stabilization. It is relevant during phases when symptoms become more noticeable, assists with symptomatic support during phases of functional strain, and supports general well-being during symptomatic phases. This helps manage symptom clusters that may become intense or disruptive, especially when symptoms are linked to heightened physiological activity.

Eligibility and Restrictions for Use

Who Can and Cannot Use Proprinal?

Proprinal, containing Ibuprofen, is defined by regulatory bodies regarding who is eligible to use it. Eligibility is determined by age, physiological status, and pre-existing medical conditions.


Absolute Contraindications (Must Not Use)

The medicine is strictly contraindicated and must not be used by individuals with a known hypersensitivity to Ibuprofen or other NSAIDs, or a history of active or recurrent gastrointestinal ulcers or bleeding. It is prohibited for patients with severe failure of the heart (NYHA Class IV), liver, or kidneys. Use is also contraindicated during the third trimester of pregnancy (after 30 weeks gestation) and for treating pain related to Coronary Artery Bypass Graft (CABG) surgery.


Restricted and Conditional Use

Use is restricted and requires caution for older adults, who face an increased risk of severe adverse reactions. Caution is mandatory for patients with mild-to-moderate renal or hepatic impairment, or uncontrolled cardiovascular disease. Pediatric use is generally not established for infants under six months of age. Use between 20 and 30 weeks of pregnancy is restricted to the lowest effective dose for the shortest duration.

What should I know about interactions with other medicines?

The use of Proprinal (ibuprofen) with certain medicinal products requires regulatory caution or is explicitly restricted due to an increased risk of adverse events or compromised therapeutic efficacy.

Documented Interaction Categories

Category Primary Interaction Concern
Other NSAIDs (Nonsteroidal Anti-inflammatory Drugs) Greatly increased risk of serious gastrointestinal bleeding.
Anticoagulants/Blood Thinners (e.g., Warfarin) Increased risk of severe stomach bleeding.
Corticosteroids (Steroid Drugs) Increased risk of severe stomach bleeding.
Aspirin (Antiplatelet) May decrease the antiplatelet benefit of low-dose aspirin for cardiovascular protection.
Diuretics May impair the blood pressure-lowering and fluid-reducing effects of diuretics.
Alcohol (Ethanol) Increased risk of severe stomach bleeding.

Regulatory Constraints

Official labeling contains specific constraints on co-administration. Proprinal must not be used with any other prescription or nonprescription drug containing an NSAID. Concomitant use with anticoagulants, antiplatelets, or oral corticosteroids increases the chance of severe stomach bleeding. If taking aspirin for heart attack or stroke prevention, timing is critical, as ibuprofen may reduce the cardiovascular benefit of aspirin. Regulatory documents advise taking Proprinal at least eight hours before or thirty minutes after non-enteric coated aspirin. Additionally, Proprinal is restricted for use right before or after coronary artery bypass graft (CABG) surgery.

Mechanism of Action

Proprinal's mechanism is defined by its ability to modulate key biological signals involved in the regulation of local inflammatory responses and central thermostasis. The active ingredient, Ibuprofen, achieves this by targeting specific enzymes and pathways.

Inhibition of Cyclooxygenase (COX) Enzymes

The primary mechanistic focus involves the reversible inhibition of the Cyclooxygenase-1 (COX-1) and Cyclooxygenase-2 (COX-2) enzymes. This molecular interaction interrupts the Arachidonic Acid Cascade, thereby sharply limiting the synthesis of Prostaglandins. This suppression of essential chemical mediators results in the modulation of overactive local signaling pathways related to Prostaglandin synthesis.

Modulating Central Thermostasis and Peripheral Signaling

The resulting physiological effects are mediated both centrally and peripherally. By reducing Prostaglandin E2 ( PGE2) concentration in the hypothalamus, the mechanism contributes to the adjustment of the thermal set-point toward basal levels. Simultaneously, the mechanism reduces PGE2 at peripheral sites, decreasing the sensitization of pain-sensing nerve endings (nociceptors) and results in a reduction of signaling activity within peripheral pathways.

Mechanism Limitations

The drug’s functional scope is inherently constrained because it does not affect the Lipoxygenase (LOX) pathway, meaning the formation of Leukotrienes (other inflammatory mediators) remains unaffected. Furthermore, the mechanism is physiologically constrained to biological processes that are predominantly mediated by Prostaglandins.

Dosage and Administration Information

How to Use Proprinal

Proprinal is available for both oral and intravenous (IV) administration, depending on the patient's immediate clinical needs. The oral form is provided as Immediate-Release (IR) tablets, Extended-Release (XL) capsules, and an oral solution.


Dosing and Frequency Patterns

Dosing is structured around a gradual titration process. For many adult indications, the regimen begins with a low starting dose, such as 40 mg administered twice daily. The typical maintenance range is generally 120 mg to 240 mg per day, and the maximum daily dose can reach 640 mg.

Administration frequency depends on the specific form. The IR tablet is typically administered multiple times per day in divided doses, while the XL capsule is administered once daily, often taken at bedtime. A critical requirement is consistency with food intake; XL capsules must be taken in the same manner—either always with food or always without it—to ensure predictable absorption.


Procedural and Population-Specific Rules

Instructions emphasize population-specific adjustments. Older adults are generally advised to start with the lowest available dosage. For pediatric use, such as the oral solution, dosing is often weight-based and requires periodic readjustment as the child's weight changes.

Treatment cessation requires a specific protocol. The drug must not be discontinued abruptly; instead, the standard protocol involves gradually reducing the dose over a period of seven to fourteen days to manage the risk of acute symptom return.

Recent Clinical Evidence

The research structure for Proprinal (Propranolol) is built upon several categories of clinical evaluation. For conditions like essential tremor, the available research is primarily built upon Randomized Controlled Trials (RCTs) and Systematic Reviews that combine data from multiple studies. These trials primarily monitored outcomes related to physical discomfort and daily functioning, particularly evaluating measurements taken in upper limb tremors. The evidence suggests that long-term effects are not fully established, and consistency of findings is lower for axial tremor symptoms (head or voice).

The evidence for the study of cardiovascular conditions (hypertension, angina, and arrhythmias) includes a large body of Multicenter RCTs and long-term observational studies. Research examined measurements of blood pressure, heart rate, and rhythm control. Regulatory data describes a consistent research base, although limited specific data for certain subgroups remain insufficient for individuals with highly resistant hypertension. Long-term effects are not fully established regarding the precise, single-factor pathway responsible for its effect on blood pressure measurements.

Research on anxiety-related physical symptoms was conducted in settings involving short-term or episodic symptom patterns, primarily focusing on the medicine’s effects on the physical manifestations. Findings describe patterns observed in the measurements of these physical symptoms during study periods, such as heart rate or sweating. However, evidence is limited and heterogeneous when applied to long-term management of general anxiety disorders. For special populations, studies have explored the medicine's use in pediatric cohorts and older adults, but evidence quality varies across these groups. This information reflects group patterns observed in studies, and research does not determine whether an individual will respond similarly.

Frequently Asked Questions (FAQ)

Common questions about Proprinal (FAQ)


Q: What is the main reason doctors prescribe Proprinal?

A: According to official documents, Proprinal is approved for the management of mild to moderate pain, the reduction of fever, and the treatment of certain inflammatory conditions, such as osteoarthritis. It is also approved for addressing the functional symptoms of conditions like essential tremor.

Q: Are there any common foods or drinks that should be avoided while using Proprinal?

A: Regulatory documents state that use with alcohol is associated with a heightened risk of serious gastrointestinal bleeding. For the extended-release capsule, product information emphasizes the importance of consistent administration (either always with food or always without) to ensure predictable absorption.

Q: Why do official materials mention a 'Boxed Warning' for some medicines like Proprinal?

A: A Boxed Warning is a regulatory tool used by the FDA to call attention to serious or life-threatening risks associated with a medicine. For Proprinal, this warning highlights the increased chance of serious events like heart attack, stroke, or severe gastrointestinal bleeding.

Q: Is Proprinal generally taken every day, or only when needed?

A: Administration frequency depends on the type of formulation and the condition being managed. The immediate-release form may be used for acute, as-needed relief, while the extended-release form is designed for once-daily administration for continuous management of certain conditions, according to official labeling.

Q: What types of conditions is Proprinal approved to treat?

A: Official information indicates that Proprinal is approved for several conditions, including the management of pain, fever reduction, rheumatic disease, and functional symptoms related to conditions such as essential tremor.

Q: Can women who are pregnant or breastfeeding use Proprinal?

A: Official guidance strictly contraindicates use after 30 weeks of pregnancy due to risks to the fetus and advises avoidance from 20 weeks onward. Information regarding safety during breastfeeding is limited and suggests the drug may pass into breast milk.

Q: Do studies suggest Proprinal has long-term effects on the heart?

A: Regulatory documents state that Proprinal increases the risk of serious cardiovascular thrombotic events, such as heart attack and stroke. This risk can begin early in treatment and may increase with higher doses and the duration of use.

Q: Does Proprinal change blood pressure in most patients?

A: Regulatory information notes that the drug may cause or worsen hypertension (high blood pressure) in some individuals. It may also impair the effectiveness of certain medications prescribed to lower blood pressure.

Q: Is Proprinal safe for use in children or teenagers?

A: The use of Proprinal is generally not established for infants under six months of age. For older children, official guidelines state that dosing is typically weight-based, and this may be subject to monitoring and adjustment.

Q: What is the official chemical name for Proprinal's active ingredient?

A: The active ingredient in Proprinal is Ibuprofen. The official chemical name is (RS)-2-(4-(2-methylpropyl)phenyl)propanoic acid.

Q: Does Proprinal affect sleep patterns?

A: Side effects reported in official documents include nervousness and, rarely, insomnia (difficulty sleeping). Separately, the extended-release form of the drug is sometimes prescribed to be administered at bedtime.

Q: Why is it important to review the list of contraindications before starting Proprinal?

A: Contraindications define specific health conditions or circumstances where a drug must not be used because the risks of severe or life-threatening adverse events are unacceptable. Reviewing this list helps to identify any pre-existing conditions that prohibit its use, as determined by regulatory criteria.

Q: What are the signs of an allergic reaction to Proprinal?

A: Signs of a serious allergic or hypersensitivity reaction described in official labels include hives, swelling of the face or throat, difficulty breathing, or symptoms of shock.

Q: Do studies show Proprinal is more effective for some patient groups than others?

A: Research indicates that findings can vary across patient groups. For example, evidence notes that the consistency of findings is lower for axial tremor symptoms and data may be limited for certain populations, such as those with highly resistant hypertension.

Q: What happens if Proprinal is taken close to bedtime?

A: The extended-release capsule formulation is often specifically labeled for once-daily administration at bedtime to ensure continuous systemic exposure. This scheduled use is part of the approved protocol for that specific formulation.

Q: Does Proprinal work right away, or does it take time to build up in the body?

A: According to official product information, the immediate-release tablet is rapidly absorbed. Peak concentrations in the blood are typically achieved one to two hours after the tablet is administered.

Q: Can Proprinal cause weight changes, according to official documents?

A: Official documents list fluid retention as a common undesirable effect of the medication. This fluid retention can, in turn, lead to an increase in body weight in some patients.

Q: How long does the effect of one dose of Proprinal typically last?

A: The half-life of the drug is approximately two to four hours. This biological measurement helps determine the administration frequency needed to maintain effective pain and fever management.

Q: Is it common for people to feel tired when they first start taking Proprinal?

A: Official lists of undesirable effects include dizziness and tiredness (fatigue) among the common reactions reported by patients. These effects are generally observed when first starting the medication.

Q: Does the body become dependent on Proprinal with long-term use?

A: Official regulatory documents, such as those from the FDA, state that Proprinal is not classified as a controlled substance by the US Drug Enforcement Administration (DEA).

Q: Are there warnings about Proprinal and driving or operating machinery?

A: Patients are advised in official product information that side effects like dizziness, visual disturbances, or drowsiness may affect their ability to drive or operate machinery. Caution is advised until the drug's effects are known.

Q: What happens if a person forgets to take a dose of Proprinal?

A: Official patient instructions indicate that a missed dose is typically taken as soon as it is remembered. However, if the time for the next scheduled dose is near, the missed dose is often instructed to be skipped to help avoid exceeding the recommended amount.

Q: Is Proprinal classified as a controlled substance?

A: Proprinal is not classified as a controlled substance by the US Drug Enforcement Administration (DEA) or other major government bodies.

Q: Does Proprinal interact with herbal supplements like St. John's Wort?

A: Official warnings note that using Proprinal with some herbal products may increase the risk of adverse effects. While the regulatory documents focus on prescription medicines, caution should be applied to all supplements.

Q: Is a metallic taste in the mouth a reported side effect of Proprinal?

A: A metallic taste in the mouth is not typically included in the official lists of common or very common side effects for Proprinal. It has not been widely reported in regulatory documents.

Q: Is there a generic version of Proprinal available?

A: The active ingredient, Ibuprofen, is off-patent. As a result, many generic versions of the drug are approved by regulatory bodies and are available to consumers.

Q: What is the typical timeframe before noticing the expected effects of Proprinal?

A: According to official summaries, relief from pain and fever typically begins within 30 minutes to one hour after taking an oral dose of the immediate-release tablet.

Q: Can men and women experience different side effects from Proprinal?

A: Clinical studies include patients of both sexes, but regulatory documents generally describe side effects based on overall population frequency. They do not typically note significant differences in side effect rates based on sex.

Q: Are there known issues with Proprinal and caffeine consumption?

A: Caffeine is not listed as a substance with a specific, regulatory-mandated interaction warning, unlike alcohol or anticoagulants. The focus of official warnings is on drug-drug and alcohol interactions.

Q: Is Proprinal a type of medicine that needs regular blood tests?

A: For patients receiving long-term therapy, regulatory guidelines typically recommend monitoring renal (kidney) function, hepatic (liver) enzymes, and blood cell counts.

Q: Can Proprinal be taken with common vitamins or mineral supplements?

A: Regulatory documents prioritize warnings about interactions with other prescribed medicines. They do not typically contain specific warnings about common vitamins or mineral supplements.

Q: How is Proprinal processed and eliminated by the body?

A: The drug is rapidly absorbed after administration and undergoes significant metabolism in the liver. It is primarily eliminated through the kidneys in the form of inactive metabolites.

Q: Do official sources mention any mental health-related side effects for Proprinal?

A: Official documents list side effects such as nervousness and dizziness. Rare reports of more significant effects like depression or psychotic reactions have also been noted.

Q: Is it necessary to have certain tests done before starting Proprinal?

A: For patients with pre-existing risks, a healthcare provider may perform baseline assessments of kidney and liver function before initiating therapy. This helps inform the assessment against safety precautions.

Q: Does Proprinal cause dry mouth?

A: Dry mouth is not listed among the common side effects. However, it has been reported as a rare or uncommon undesirable effect in official regulatory documents.

Q: Why does the packaging for Proprinal contain a patient information leaflet?

A: The patient information leaflet is a regulatory requirement established by government agencies. Its purpose is to ensure the patient receives clear, official information regarding the drug's approved uses, risks, and necessary storage conditions.

Q: Can Proprinal interfere with the results of certain medical tests?

A: Regulatory documents note that the drug may interfere with tests designed to measure the urinary excretion of metabolites, such as those for 5-HIAA (5-hydroxyindoleacetic acid).

Q: Is there a maximum time frame for using Proprinal, according to research?

A: For over-the-counter use, the duration is typically limited by regulatory advice to 10 days for pain and 3 days for fever. Prescription use may extend longer, but is typically restricted to the shortest possible duration.

How should Proprinal be stored and disposed of?

How to Store and Dispose of Proprinal

Storage of Proprinal (Ibuprofen) must strictly follow the conditions specified in official regulatory labeling.


Storage Requirements

Condition Regulatory Requirement
Temperature Store at controlled room temperature, 20 C to 25 C (68 F to 77 F).
Protection Keep the container tightly closed to protect from moisture. Do not freeze oral suspensions.
Packaging Must be stored in the original container and secured out of the sight and reach of children.

Disposal Instructions

Unused or expired Proprinal must be disposed of in accordance with local regulations for pharmaceutical waste. The preferred disposal method is typically a medicine take-back program. The product must not be flushed down the toilet or poured down a drain unless the specific product label provides explicit instructions to do so.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Proprinal found in:

A-Z Index: